MYL2 Gene Cardiomyopathy familial hypertrophic type 10 Genetic Test
Test Name: MYL2 Gene Cardiomyopathy familial hypertrophic type 10 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Cardiovascular Pneumology Disorders
Doctor: Cardiologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for MYL2 Gene Cardiomyopathy, familial hypertrophic type 10 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYL2 Gene Cardiomyopathy, familial hypertrophic type 10 NGS Genetic DNA Test gene MYL2
Test Details: The MYL2 gene is associated with familial hypertrophic cardiomyopathy, which is a genetic condition characterized by the thickening of the heart muscle. This condition can lead to various cardiac problems, including heart failure, arrhythmias, and sudden cardiac death. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify genetic variations or mutations associated with certain diseases or conditions. In the case of familial hypertrophic cardiomyopathy, NGS testing can help identify specific mutations in the MYL2 gene that may be responsible for the development of the condition. By performing this genetic test, healthcare providers can provide a more accurate diagnosis, assess the risk of developing cardiomyopathy in family members, and guide appropriate treatment and management strategies. Genetic counseling is often recommended before and after genetic testing to discuss the implications of the test results and help individuals and families make informed decisions regarding their healthcare.
Test Name | MYL2 Gene Cardiomyopathy familial hypertrophic type 10 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MYL2 Gene Cardiomyopathy, familial hypertrophic type 10 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYL2 Gene Cardiomyopathy, familial hypertrophic type 10 NGS Genetic DNA Test gene MYL2 |
Test Details |
The MYL2 gene is associated with familial hypertrophic cardiomyopathy, which is a genetic condition characterized by the thickening of the heart muscle. This condition can lead to various cardiac problems, including heart failure, arrhythmias, and sudden cardiac death. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify genetic variations or mutations associated with certain diseases or conditions. In the case of familial hypertrophic cardiomyopathy, NGS testing can help identify specific mutations in the MYL2 gene that may be responsible for the development of the condition. By performing this genetic test, healthcare providers can provide a more accurate diagnosis, assess the risk of developing cardiomyopathy in family members, and guide appropriate treatment and management strategies. Genetic counseling is often recommended before and after genetic testing to discuss the implications of the test results and help individuals and families make informed decisions regarding their healthcare. |